ATE415147T1 - Verwendung von inhibitoren exzitatorischer aminosäuren in kosmetischen oder dermatologischen zubereitungen für empfindliche haut sowie zubereitung - Google Patents

Verwendung von inhibitoren exzitatorischer aminosäuren in kosmetischen oder dermatologischen zubereitungen für empfindliche haut sowie zubereitung

Info

Publication number
ATE415147T1
ATE415147T1 AT98402327T AT98402327T ATE415147T1 AT E415147 T1 ATE415147 T1 AT E415147T1 AT 98402327 T AT98402327 T AT 98402327T AT 98402327 T AT98402327 T AT 98402327T AT E415147 T1 ATE415147 T1 AT E415147T1
Authority
AT
Austria
Prior art keywords
cosmetic
amino acids
inhibitors
preparation
sensitive skin
Prior art date
Application number
AT98402327T
Other languages
English (en)
Inventor
Lionel Breton
Isabelle Nonotte
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE415147T1 publication Critical patent/ATE415147T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98402327T 1997-09-25 1998-09-22 Verwendung von inhibitoren exzitatorischer aminosäuren in kosmetischen oder dermatologischen zubereitungen für empfindliche haut sowie zubereitung ATE415147T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9711959A FR2768624B1 (fr) 1997-09-25 1997-09-25 Utilisation d'un inhibiteur d'acides amines excitateurs dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue

Publications (1)

Publication Number Publication Date
ATE415147T1 true ATE415147T1 (de) 2008-12-15

Family

ID=9511487

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98402327T ATE415147T1 (de) 1997-09-25 1998-09-22 Verwendung von inhibitoren exzitatorischer aminosäuren in kosmetischen oder dermatologischen zubereitungen für empfindliche haut sowie zubereitung

Country Status (8)

Country Link
US (3) US6616933B1 (de)
EP (1) EP0904777B1 (de)
JP (2) JP3712328B2 (de)
AT (1) ATE415147T1 (de)
CA (1) CA2245206C (de)
DE (1) DE69840253D1 (de)
ES (1) ES2318866T3 (de)
FR (1) FR2768624B1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874463A (en) * 1994-10-24 1999-02-23 Ancira; Margaret Hydroxy-kojic acid skin peel
FR2768624B1 (fr) * 1997-09-25 1999-11-12 Oreal Utilisation d'un inhibiteur d'acides amines excitateurs dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue
WO1999045906A1 (en) * 1998-03-09 1999-09-16 Trustees Of Tufts College Treatment of compulsive behaviours in man and animals
US20070197651A1 (en) * 1998-03-09 2007-08-23 Tufts University Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors
US20060167114A1 (en) * 1998-03-09 2006-07-27 Louis Shuster Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors
JP2001233764A (ja) * 2000-02-22 2001-08-28 Hisamitsu Pharmaceut Co Inc Ｎ−置換−ｏ−トルイジン誘導体からなる鎮痒剤
US20020140819A1 (en) * 2001-04-02 2002-10-03 Pelco Customizable security system component interface and method therefor
JP2003081872A (ja) * 2001-09-13 2003-03-19 Nippon Oruganon Kk 掻痒治療薬
US20040126351A1 (en) * 2002-12-26 2004-07-01 Avon Products, Inc. Topical composition having natural skin anti-irritant ingredient and method of use
DK1477166T3 (da) * 2003-04-28 2006-12-11 Biofrontera Bioscience Gmbh Anvendelse af riluzoler kombineret med egnede hjælpe- og tilsætningsstoffer til behandling af sygdomme, som er kendetegnet ved en hyperproliferation af keratinocytter, navnlig neurodermitis og psoriasis
GB0623897D0 (en) * 2006-11-30 2007-01-10 Pliva Istrazivanje I Razvoj D Pharmaceutical composition of memantine
MX2010005190A (es) 2008-02-08 2010-06-03 Colgate Palmolive Co Hilo dental.
EP2249791A4 (de) * 2008-02-08 2014-01-08 Colgate Palmolive Co Zusammensetzungen und vorrichtungen
AU2009212339B2 (en) * 2008-02-08 2011-12-22 Colgate-Palmolive Company Tooth sealant
TWI432188B (zh) 2008-12-19 2014-04-01 Merz Pharma Gmbh & Co Kgaa 供治療發炎性皮膚疾病之１－胺基－烷基環己烷衍生物類
AU2009328497A1 (en) 2008-12-19 2010-06-24 Merz Pharma Gmbh & Co. Kgaa 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
EP2490669B1 (de) * 2009-10-23 2017-01-11 Fortuderm Ltd. Triptane zur behandlung von schuppenflechte
CN102858321A (zh) * 2010-06-18 2013-01-02 莫茨药物股份两合公司 用于局部使用1-氨基-烷基环己烷衍生物的凝胶制剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3046346B2 (ja) * 1990-03-12 2000-05-29 昭和電工株式会社 外用剤基剤又は補助剤とそれを含有する人又は動物の外用剤
WO1992017168A1 (en) * 1991-04-04 1992-10-15 The Children's Medical Center Corporation Method of preventing nmda receptor-mediated neuronal damage
MX9204914A (es) * 1991-08-28 1993-07-01 Frank Watjen Nuevos derivados de isatinoxima, metodo para su preparacion y composicion farmaceutica que los comprende.
US6190691B1 (en) * 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US6203803B1 (en) 1994-12-14 2001-03-20 Societe L'oreal S.A. Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained
FR2719474B1 (fr) * 1994-05-05 1996-05-31 Oreal Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.
DE4423450C2 (de) 1994-07-05 1997-07-24 Beiersdorf Ag Verwendung anorganischer Pigmente in kosmetischen oder dermatologischen Zubereitungen, welche alpha-Hydroxycarbonsäuren und/oder alpha-Ketocarbonsäuren enthalten
FR2728265A1 (fr) * 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p dans une composition pharmaceutique
US5607980A (en) * 1995-07-24 1997-03-04 The Procter & Gamble Company Topical compositions having improved skin feel
US6197830B1 (en) * 1995-09-22 2001-03-06 Bruce M. Frome Method for achieving relief from sympathetically mediated pain
US5817699A (en) * 1997-05-30 1998-10-06 Flores; John A. Process for the preparation of ketamine ointment
FR2768624B1 (fr) * 1997-09-25 1999-11-12 Oreal Utilisation d'un inhibiteur d'acides amines excitateurs dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue

Also Published As

Publication number Publication date
CA2245206C (fr) 2006-05-23
FR2768624B1 (fr) 1999-11-12
EP0904777A1 (de) 1999-03-31
US7601360B2 (en) 2009-10-13
US20030202994A1 (en) 2003-10-30
CA2245206A1 (fr) 1999-03-25
US20100004311A1 (en) 2010-01-07
ES2318866T3 (es) 2009-05-01
US6616933B1 (en) 2003-09-09
JP3712328B2 (ja) 2005-11-02
JPH11158027A (ja) 1999-06-15
EP0904777B1 (de) 2008-11-26
DE69840253D1 (de) 2009-01-08
JP2002193834A (ja) 2002-07-10
FR2768624A1 (fr) 1999-03-26

Similar Documents

Publication Publication Date Title
DE69840253D1 (de) Verwendung von Inhibitoren exzitatorischer Aminosäuren in kosmetischen oder dermatologischen Zubereitungen für empfindliche Haut sowie Zubereitung
EP0801946A3 (de) Verwendung von Salicin als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen
DE69531870D1 (de) Verwendung von sophoroselipiden in kosmetischen und dermatologischen zusammensetzungen
DE69405636D1 (de) Verwendung von einem Alkylester in einer kosmetischen oder dermatologischen Zusammensetzung zur topischen Behandlung von der Hautalterung
DE69716251D1 (de) Verwendung von oktoxyglyzerin in einer kosmetische und/oder dermatologische zusammensetzung zur behandlung von seborrhea und akne
BR9800660A (pt) Emulsão água-em-óleo sua utilização composição cosmética e/ou dermatológica processo de tratamento cosmético e utilzação de uma associação
ATE137665T1 (de) Kosmetisches mittel
DE59209963D1 (de) Proteinfraktion zur kosmetischen und dermatologischen Pflege der Haut
DE59307584D1 (de) Verwendung von kationischen polyurethanen und polyharnstoffen als hilfsmittel in kosmetischen und pharmazeutischen zubereitungen
NO973900L (no) Nitrogenoksyd syntase inhibitor
BR9501652A (pt) Usos de um antagonista de substancia P em uma composição cosmética processo de tratamento cosmético composição cosmética e uso da capsaicina
BR9802120A (pt) Composição cosmética e/ou dermatológica composição dermatologica processo de tratamento cosmético utilização de uma composição processo de conservação de composições e utilização de um polímero poliaminado
DE69810649D1 (de) Verwendung von ellagsäure und ihren derivaten in der kosmetik und der dermatologie
ATE167393T1 (de) Verfahren zur hautpflege und mittel
DE59703511D1 (de) Kosmetikum bzw. kosmetikzusammensetzung zur glättung und straffung der haut bei gestörtem unterhaut-binde-fettgewebe, insbesondere bei der "cellulite"
DK130387A (da) Transglutaminase inhibitorer
DE59407737D1 (de) Verwendung von alkandiolen in kosmetischen produkten
DE69928005D1 (de) Kosmetische und dermatologische zusammensetzung enthaltend einen wirkstoff zur stimulierung der synthese des hsp 32 proteins in der haut und verfahren zur kosmetischen behandlung
DE59812513D1 (de) Verwendung von W/O-Emulsionen als Verdicker in kosmetischen und pharmazeutischen Zubereitungen
DE69400727D1 (de) Verwendung von 4-Thiuoresorcin-Derivaten in kosmetischen oder dermopharmazeutischen Zusammensetzungen zur Hautdepigmentierung
DE69700333D1 (de) Verwendung von Oxazolidinon-Derivaten als penetrations-verhindernde Mittel in einer kosmetischen und/oder dermatologischen Zusammensetzung
DE69803200D1 (de) Verwendung von mindestens einen chrysanthemum gattungs extrakten zur förderung der haut- und/oder der haarepigmentierung
DE3671365D1 (de) Topische anwendung des 3-phenylacetylamino-2,6-piperidindions zur behandlung von hautfalten und hyperpigmentierung.
DE59807831D1 (de) Verwendung von ascorbyl-2-phosphorsäureestern zur stabilisierung von vitamin a und/oder vitamin a-derivaten in kosmetischen und pharmazeutischen zubereitungen
EP0801945A3 (de) Verwendung von Glucosiden von Ferulasäure als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties